Shanghai Zerun Biotechnology, Walvax Biotechnology: 202-CoV

Vaccine Type: Protein Subunit

This vaccine may also be referred to as ZR-202-CoV

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 2 trials.

About Trial Phases

Phase 1: 3 Trials

Phase 2: 3 Trials

Phase 3: 0 Trials

There are no trials for this phase.


This vaccine is not yet approved.

Registered Trials